[Form 3] Perspective Therapeutics, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Perspective Therapeutics, Inc. (CATX) filed a Form 3 reporting Maria E. Martinez as a Director and a reporting person. The event date listed is 09/03/2025. The filing states explicitly that no securities are beneficially owned by the reporting person and references Exhibit 24 (Power of Attorney). The form is signed by Maria E. Martinez via attorney-in-fact on 09/05/2025.

Positive

• Director status disclosed for Maria E. Martinez, clarifying governance roles
• Form 3 filed and signed (via attorney-in-fact), providing an official initial disclosure

Negative

• No securities beneficially owned by the reporting director as stated in the filing

Insights

Corporate Governance Analyst

Director Maria E. Martinez filed an initial Form 3 and reports no beneficial ownership.

This Form 3 discloses the appointment/relationship of Maria E. Martinez as a director and confirms she currently holds no securities of Perspective Therapeutics.

For governance and investor-alignment purposes, a director with no reported holdings is a factual disclosure investors and compliance teams use to assess director stake and potential conflicts. The filing includes Exhibit 24 (Power of Attorney) and is signed on 09/05/2025.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Martinez Maria E

(Last) (First) (Middle)

C/O PERSPECTIVE THERAPEUTICS, INC.

2401 ELLIOTT AVENUE, SUITE 320

(Street)

SEATTLE WA 98121

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/03/2025

3. Issuer Name and Ticker or Trading Symbol
Perspective Therapeutics, Inc. [ CATX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

1. No securities are beneficially owned. 2. Exhibit 24 - Power of Attorney.

No securities are beneficially owned.

	/s/ Maria E Martinez by Chris Nenno, as Attorney-in-Fact	09/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 3 for Perspective Therapeutics (CATX)?

The Form 3 was filed by Maria E. Martinez, listed as a Director of Perspective Therapeutics.

Does the Form 3 report any stock ownership for Maria E. Martinez?

The filing explicitly states no securities are beneficially owned by Maria E. Martinez.

What is the event date reported on the Form 3?

The event date on the Form 3 is 09/03/2025.

When was the Form 3 signed?

The signature block shows the form was signed by Maria E. Martinez (by attorney-in-fact) on 09/05/2025.

Does the filing include any exhibits?

Yes, the filing references Exhibit 24, the Power of Attorney.